The landscape of metabolic management is rapidly evolving , with the emergence of dual GIP and GLP-1 receptor agonists. Both Tirzepatid and Retatrutide represent significant advancements; Tirzepatide already https://retatrutide-40mg547771.techionblog.com/profile